Home Cart Sign in  
Chemical Structure| 360-65-6 Chemical Structure| 360-65-6

Structure of Glycodeoxycholic Acid
CAS No.: 360-65-6

Chemical Structure| 360-65-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Glycodeoxycholic Acid is an endogenous metabolite.

Synonyms: GDCA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Glycodeoxycholic Acid

CAS No. :360-65-6
Formula : C26H43NO5
M.W : 449.62
SMILES Code : O=C(CNC(CC[C@@H](C)[C@H]1CC[C@]2([C@@]3(CC[C@]4([H])C[C@@H](CC[C@@]4([C@]3(C[C@@H]([C@]12C)O)[H])C)O)[H])[H])=O)O
Synonyms :
GDCA
MDL No. :MFCD00067133
InChI Key :WVULKSPCQVQLCU-BUXLTGKBSA-N
Pubchem ID :3035026

Safety of Glycodeoxycholic Acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 cells 0 μM, 10 μM 14 days GDCA strongly promotes clonogenicity of HCT116 cells EPMA J. 2022 Jan 27;13(1):39-55
FHC cells 0 μM, 2 μM, 5 μM, 10 μM 4 days GDCA has no effect on FHC cell viability EPMA J. 2022 Jan 27;13(1):39-55
HCT8 cells 0 μM, 2 μM, 5 μM, 10 μM 4 days GDCA promotes proliferation of HCT8 cells EPMA J. 2022 Jan 27;13(1):39-55
HCT116 cells 0 μM, 2 μM, 5 μM, 10 μM 4 days GDCA promotes proliferation of HCT116 cells EPMA J. 2022 Jan 27;13(1):39-55
LO2 cells 0.5 mM 14 days GDCA had no significant effect on the growth of LO2 cells Hepatol Int. 2022 Apr;16(2):396-411
Primary rat hepatocytes 50 µM 30 minutes To investigate the activation of ERK1/2 and AKT signaling pathways by GDCA, results showed that GDCA activated ERK1/2 and AKT pathways, and this activation was inhibited by the S1P2 antagonist JTE-013. Hepatology. 2012 Jan;55(1):267-76
mouse bone marrow-derived monocyte/macrophages (BMDMs) 100 μmol/L 6 hours GDCA upregulated ZBP1 expression through sphingosine 1-phosphate receptor 2 (S1PR2) and induced ZBP1/p-MLKL-mediated necroptosis. Cell Death Dis. 2023 Mar 1;14(3):175
HepG2 cells 0.5 mM 24 hours GDCA significantly increased the apoptosis rate of HepG2 cells Hepatol Int. 2022 Apr;16(2):396-411
SUN-449 cells 0.5 mM 24 hours GDCA significantly increased the apoptosis rate of SUN-449 cells Hepatol Int. 2022 Apr;16(2):396-411
HepG2 cells 0.5 mM 14 days GDCA significantly inhibited the clone formation rate of HepG2 cells Hepatol Int. 2022 Apr;16(2):396-411
SUN-449 cells 0.5 mM 14 days GDCA significantly inhibited the clone formation rate of SUN-449 cells Hepatol Int. 2022 Apr;16(2):396-411

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nu/nu female mice Subcutaneous tumor transplant model Gastric gavage 200 mg/kg Once a day for 1 month GDCA significantly inhibited the growth of HCC tumors Hepatol Int. 2022 Apr;16(2):396-411

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.22mL

0.44mL

0.22mL

11.12mL

2.22mL

1.11mL

22.24mL

4.45mL

2.22mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records